Actinium Pharmaceuticals Stock Forward View
| ATNM Stock | USD 1.23 0.01 0.82% |
Actinium Stock outlook is based on your current time horizon. Although Actinium Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Actinium Pharmaceuticals' systematic risk associated with finding meaningful patterns of Actinium Pharmaceuticals fundamentals over time.
As of now, the RSI of Actinium Pharmaceuticals' share price is approaching 42. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Actinium Pharmaceuticals, making its price go up or down. Momentum 42
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (1.08) | EPS Estimate Next Year (0.79) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.32) |
Using Actinium Pharmaceuticals hype-based prediction, you can estimate the value of Actinium Pharmaceuticals from the perspective of Actinium Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Actinium Pharmaceuticals using Actinium Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Actinium using crowd psychology based on the activity and movement of Actinium Pharmaceuticals' stock price.
Actinium Pharmaceuticals Implied Volatility | 0.81 |
Actinium Pharmaceuticals' implied volatility exposes the market's sentiment of Actinium Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Actinium Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Actinium Pharmaceuticals stock will not fluctuate a lot when Actinium Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Actinium Pharmaceuticals on the next trading day is expected to be 1.28 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.63. Actinium Pharmaceuticals after-hype prediction price | USD 1.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Actinium Pharmaceuticals to cross-verify your projections. Open Interest Against 2026-03-20 Actinium Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Actinium Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Actinium Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Actinium Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Actinium Pharmaceuticals' open interest, investors have to compare it to Actinium Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Actinium Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Actinium. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Actinium Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Actinium price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Actinium using various technical indicators. When you analyze Actinium charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Actinium Pharmaceuticals Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Actinium Pharmaceuticals' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2006-12-31 | Previous Quarter 59.9 M | Current Value 53.4 M | Quarterly Volatility 34.5 M |
Actinium Pharmaceuticals Naive Prediction Price Forecast For the 31st of January
Given 90 days horizon, the Naive Prediction forecasted value of Actinium Pharmaceuticals on the next trading day is expected to be 1.28 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.63.Please note that although there have been many attempts to predict Actinium Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Actinium Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Actinium Pharmaceuticals Stock Forecast Pattern
| Backtest Actinium Pharmaceuticals | Actinium Pharmaceuticals Price Prediction | Buy or Sell Advice |
Actinium Pharmaceuticals Forecasted Value
In the context of forecasting Actinium Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Actinium Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 5.26, respectively. We have considered Actinium Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Actinium Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Actinium Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.3842 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0431 |
| MAPE | Mean absolute percentage error | 0.0303 |
| SAE | Sum of the absolute errors | 2.6287 |
Predictive Modules for Actinium Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Actinium Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Actinium Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Actinium Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Actinium Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Actinium Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Actinium Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Actinium Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Actinium Pharmaceuticals' historical news coverage. Actinium Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.06 and 5.20, respectively. We have considered Actinium Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Actinium Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Actinium Pharmaceuticals is based on 3 months time horizon.
Actinium Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Actinium Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Actinium Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Actinium Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 3.98 | 0.01 | 0.00 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.23 | 1.23 | 0.00 |
|
Actinium Pharmaceuticals Hype Timeline
Actinium Pharmaceuticals is presently traded for 1.23. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. Actinium is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at -0.12%. %. The volatility of related hype on Actinium Pharmaceuticals is about 23411.76%, with the expected price after the next announcement by competition of 1.23. About 20.0% of the company shares are held by institutions such as insurance companies. The book value of Actinium Pharmaceuticals was presently reported as 0.44. The company recorded a loss per share of 1.11. Actinium Pharmaceuticals last dividend was issued on the 11th of August 2020. The entity had 1:30 split on the 11th of August 2020. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Historical Fundamental Analysis of Actinium Pharmaceuticals to cross-verify your projections.Actinium Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Actinium Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Actinium Pharmaceuticals' future price movements. Getting to know how Actinium Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Actinium Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PDSB | PDS Biotechnology Corp | 0.01 | 11 per month | 4.67 | (0) | 8.60 | (8.41) | 27.78 | |
| LVTX | LAVA Therapeutics NV | (0.09) | 27 per month | 1.19 | 0.06 | 4.70 | (2.63) | 14.75 | |
| XLO | Xilio Development | (0.01) | 10 per month | 0.00 | (0.14) | 4.69 | (5.56) | 15.41 | |
| TPST | Tempest Therapeutics | 0.07 | 6 per month | 0.00 | (0.18) | 7.92 | (9.56) | 57.69 | |
| OKUR | OnKure Therapeutics | 0.02 | 9 per month | 4.36 | (0) | 9.79 | (6.92) | 23.27 | |
| RVPH | Reviva Pharmaceuticals Holdings | (0.01) | 8 per month | 0.00 | (0.07) | 10.71 | (12.50) | 65.06 | |
| FGEN | FibroGen | 0.02 | 12 per month | 0.00 | (0.06) | 4.33 | (5.28) | 28.75 | |
| KZR | Kezar Life Sciences | 0.02 | 11 per month | 1.04 | (0.05) | 1.46 | (1.28) | 7.79 | |
| TVRD | Tvardi Therapeutics | (0.11) | 7 per month | 0.00 | (0.11) | 5.59 | (5.80) | 17.33 | |
| ANVS | Annovis Bio | (0.09) | 23 per month | 5.23 | 0.11 | 14.79 | (9.57) | 41.06 |
Other Forecasting Options for Actinium Pharmaceuticals
For every potential investor in Actinium, whether a beginner or expert, Actinium Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Actinium Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Actinium. Basic forecasting techniques help filter out the noise by identifying Actinium Pharmaceuticals' price trends.Actinium Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Actinium Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Actinium Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Actinium Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Actinium Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Actinium Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Actinium Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Actinium Pharmaceuticals stock market strength indicators, traders can identify Actinium Pharmaceuticals entry and exit signals to maximize returns.
Actinium Pharmaceuticals Risk Indicators
The analysis of Actinium Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Actinium Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting actinium stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.07 | |||
| Standard Deviation | 3.98 | |||
| Variance | 15.85 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Actinium Pharmaceuticals
The number of cover stories for Actinium Pharmaceuticals depends on current market conditions and Actinium Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Actinium Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Actinium Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Actinium Pharmaceuticals Short Properties
Actinium Pharmaceuticals' future price predictability will typically decrease when Actinium Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Actinium Pharmaceuticals often depends not only on the future outlook of the potential Actinium Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Actinium Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.1 M | |
| Cash And Short Term Investments | 72.9 M |
Check out Historical Fundamental Analysis of Actinium Pharmaceuticals to cross-verify your projections. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Biotechnology sector continue expanding? Could Actinium diversify its offerings? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Actinium Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.11) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
Understanding Actinium Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Actinium's accounting equity. The concept of intrinsic value—what Actinium Pharmaceuticals' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Actinium Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that Actinium Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Actinium Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Actinium Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.